HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)
CNY 8.18
(-5.43%)
CNY 8.18
(-5.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.38 Billion | 9.64 Billion | 9.31 Billion | 8 Billion | 8.35 Billion | 7.05 Billion |
| Cost of Revenue | 9.4 Billion | 8.72 Billion | 8.32 Billion | 7.08 Billion | 7.33 Billion | 6.15 Billion |
| Gross Profit | 986.11 Million | 917.53 Million | 995.13 Million | 916.81 Million | 1.02 Billion | 904.13 Million |
| Operating Expenses | 586.72 Million | 540.62 Million | 572.91 Million | 653.54 Million | 610.53 Million | 549.21 Million |
| Selling, General and Administrative Expenses | 544.01 Million | 434.23 Million | 464.37 Million | 519.51 Million | 392.43 Million | 278.13 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 42.71 Million | 106.38 Million | 108.53 Million | 134.03 Million | 218.1 Million | 17.77 Million |
| Cost and Expenses | 9.99 Billion | 9.26 Billion | 8.89 Billion | 7.74 Billion | 7.94 Billion | 6.7 Billion |
| Operating Income | 411.84 Million | 347.4 Million | 360.62 Million | 220.14 Million | 363.72 Million | 349.86 Million |
| Interest Expense | 36.33 Million | 44.42 Million | 50.31 Million | 30.75 Million | 25.27 Million | 24.44 Million |
| Income Tax Expense | 101.13 Million | 82.14 Million | 82.09 Million | 74.73 Million | 93.96 Million | 87.85 Million |
| Earnings before Tax | 393.38 Million | 345.55 Million | 358.6 Million | 219.69 Million | 361.26 Million | 345.71 Million |
| Net Income | 292.16 Million | 264.47 Million | 277.29 Million | 145.26 Million | 267.33 Million | 257.85 Million |
| Earnings Per Share Basic | 0.50 | 0.46 | 0.48 | 0.25 | 0.46 | 0.44 |
| Earnings Per Share Diluted | 0.50 | 0.46 | 0.48 | 0.25 | 0.46 | 0.44 |
| Weighted Average Shares Outstanding | 579.91 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 579.91 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.85 Million |
| Gross Margin | 0.09 | 0.10 | 0.11 | 0.11 | 0.12 | 0.13 |
| EBIT Margin | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 |
| Profit Margin | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 |
| EBITDA | 474.3 Million | 442.75 Million | 469.35 Million | 275.35 Million | 413.1 Million | 382.76 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.05 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.69 Billion | 2.37 Billion | 2.58 Billion | 10.35 Billion | 2.55 Billion | 2.54 Billion |
| Cost of Revenue | 2.46 Billion | 2.19 Billion | 2.35 Billion | 9.45 Billion | 2.31 Billion | 2.3 Billion |
| Gross Profit | 228.57 Million | 187.59 Million | 232.81 Million | 909.48 Million | 235.25 Million | 242.79 Million |
| Operating Expenses | 127.41 Million | 120.98 Million | 127 Million | 497.64 Million | 142.41 Million | 130.67 Million |
| Selling, General and Administrative Expenses | 304.59 Million | 120.98 Million | 127 Million | - | 141.52 Million | 161.33 Million |
| Research and Development Expenses | - | 584.25 Thousand | - | - | - | - |
| Other Expenses | -177.18 Million | 699.35 Thousand | -84.43 Thousand | 80.23 Thousand | -886.41 Thousand | -12.91 Million |
| Cost and Expenses | 2.59 Billion | 2.31 Billion | 2.48 Billion | 9.94 Billion | 2.46 Billion | 2.43 Billion |
| Operating Income | 93.71 Million | 66.61 Million | 105.81 Million | 411.84 Million | 92.84 Million | 108.43 Million |
| Interest Expense | 5.47 Million | 7.23 Million | 6.53 Million | 27.22 Million | 7.25 Million | 5.35 Million |
| Income Tax Expense | 22.58 Million | 17.25 Million | 24.46 Million | 101.13 Million | 29.15 Million | 21.04 Million |
| Earnings before Tax | 93.39 Million | 74.11 Million | 102.79 Million | 393.38 Million | 80.76 Million | 108.24 Million |
| Net Income | 70.81 Million | 56.85 Million | 78.33 Million | 292.16 Million | 51.62 Million | 87.19 Million |
| Earnings Per Share Basic | 0.12 | 0.10 | 0.14 | - | 0.09 | 0.15 |
| Earnings Per Share Diluted | 0.12 | 0.10 | 0.14 | - | 0.09 | 0.15 |
| Weighted Average Shares Outstanding | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million | 579.88 Million |
| Gross Margin | 0.08 | 0.08 | 0.09 | 0.09 | 0.09 | 0.10 |
| EBIT Margin | 0.04 | 0.03 | 0.04 | - | 0.04 | 0.05 |
| Profit Margin | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 |
| EBITDA | 98.86 Million | 82.12 Million | 112.53 Million | - | 108.28 Million | 119.05 Million |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
PMMP
000230
DGN
600216
FLEW
GAME